ClinicalTrials.gov
public full text
Public Domain
Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC)
This phase I/II is studying the side effect and best dose of Z-208 for patients with advanced hepatocellular carcinoma
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia#899081
- RAD001 and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Carcinoma In Situ of the Bladder#1047296
- Comprehensive Health Assessment for My Plan: Initial Implementation Study (CHAMP Implementation Study)#1058120
- A Multicenter, Prospective, Non-interventional Cohort Study to Evaluate the Safety and Treatment Pattern of Sodium Zirconium Cyclosilicate for Hyperkalaemia Management in Real World Practice in China#886756
- Zinc Supplementation on Cellular Immunity in Thalassemia Major#903195
Record · ID 851134
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive